, Evaluation (Follow-up)
, Evidence-Based Guidelines
, Health Behavior
, Men's Health
, STDs (Sexually Transmitted Infections)
, Women's Health
Accelerating Cervical Cancer Prevention Through HPV Vaccine Uptake
Release Date: November 15, 2016
Expiration Date: October 31, 2018
- CE for this activity will not be available after this date.
Overview: In 2012, the President's Cancer Panel determined that low rates of adolescent, HPV vaccine uptake were a threat to America's progress against cancer. Missed clinical opportunities are the most important reason why the U.S. has not achieved the Healthy People 2002 target of 80% vaccine uptake. The CDC estimates that increasing current, low, vaccination rates would prevent, for example, an additional 53,000 future cervical cancer cases in the U.S. Adolescents receive other recommended vaccines during visits with their healthcare provider, but not HPV vaccines. In the U.S., there are three licensed, safe, and effective HPV cancer prevention vaccines recommended by the CDC's Advisory Committee on Immunization Practices. Studies show that a strong healthcare provider recommendation is the single best predictor of vaccination. Although HPV cancer prevention vaccine uptake is low, vaccination is making a difference! HPV vaccine uptake has decreased HPV related diseases and cancers; especially when received prior to coitarche and as a means of primary prevention. NPs play a key role in decision making regarding HPV vaccination. It is critical that we continue to address barriers and implement successful interventions and strategies for encouraging HPV vaccine uptake. It will take a joint effort among health care systems, the community, and the family support to make an impact on HPV infection, disease and cancer. This activity increases the knowledge and clinical confidence of Primary Care Nurse Practitioners addressing HPV cancer prevention vaccine uptake. Learners will understand HPV vaccine uptake barriers; successful interventions and strategies used to encourage HPV vaccine uptake; and clinical indications and impact of the quadrivalent, bivalent and the newly approved 9‐Valent HPV vaccines.
This CE activity is a recording of a CE session from the AANP 2016 National Conference. It has been edited to meet the format requirements for online learning. If you received CE credit for attending the live session at Conference, you many not receive duplication credit for this same activity in a different format.
Objectives: Upon completion of the this activity the learner will be able to:
- Describe the impact of HPV vaccination on HPV-related disease & cancer burden in the US
- Describe the impact of missed clinical opportunities for HPV vaccination update in the US
- Differentiate between HPV-related disease & cancer burden among women and men in the US
- Identify four interventions & strategies that positively impact the uptake of HPV vaccination
- Explain the significance & role of the nurse practitioner’s strong recommendation as a predictor of HPV vaccination.
Elizabeth A. Kostas‐Polston, PhD, APRN, WHNP‐BC, FAANP, FAAN;
Versie Johnson‐ Mallard, PhD, WHNP‐BC, FAANP, FAAN
This activity was planned in accordance with AANP Accreditation Standards and Policies. Dr. Kostas-Polston and Dr. Johnson-Mallard have no relevant financial affiliations to disclose.
This educational activity may contain opinions of the speaker from their personal experience. The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit: To complete the CE for this activity, review all the content, successfully complete on the online post-test and submit the online program evaluation.
For questions about this online CE activity, or more information concerning the AANP CE Center, please contact the AANP CE Center Manager at CECenter@aanp.org.